Nuclear Localization of Endothelin-Converting Enzyme-1: Subisoform Specificity

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 12, 2003, Pages 2192-2196

  Jafri, Farahdiba ^a   Ergul, Adviye ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Endothelin; High glucose; Subcellular localization

Indexed keywords

BIG ENDOTHELIN 1; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; GLUCOSE; GREEN FLUORESCENT PROTEIN; ISOENZYME; RECOMBINANT ENZYME;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CULTURE MEDIUM; CYTOPLASM; ENDOTHELIUM CELL; ENZYME LOCALIZATION; ENZYME SPECIFICITY; GENETIC TRANSFECTION; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REGULATORY MECHANISM;

ANIMALS; CAPILLARIES; CELL LINE; CELL NUCLEUS; CHO CELLS; CRICETINAE; CRICETULUS; ENDOTHELINS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GREEN FLUORESCENT PROTEINS; HUMANS; ISOENZYMES; LUMINESCENT PROTEINS; METALLOENDOPEPTIDASES; RECOMBINANT FUSION PROTEINS; SUBSTRATE SPECIFICITY; TRANSFECTION;

EID: 0347383734     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000099787.21778.55     Document Type: Article

References (21)

1. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989;86:2864-2867.
2. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46:325-415.
3. Yanagisawa H, Hammer RE, Richardson JA, Emoto N, Williams SC, Takeda S-I, Clouthier DE, Yanagisawa M. Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J Clin Invest. 2000;105:1373-1382.
4. Yanagisawa M, Kurihara H, Kimura S, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
5. Turner AJ, Barnes K, Schweizer A, Valdenaire O. Isoforms of endothelin converting enzyme: why and where? Trends Pharmacol Sci. 1998;19:483-486.
6. Turner AJ, Murphy LJ. Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol. 1996;51:91-102.
7. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M. A membrane-bound metalloproteinase that catalyzes the proteolytic activation of big endothelin-1. Cell. 1994;78:473-485.
8. Emoto N, Yanagisawa M. Endothelin converting enzyme-2 is a membrane bound phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem. 1995;270:15262-15268.
9. Hasegawa H, Hiki K, Sawamura T, Aoyama T, Okamoto Y, Miwa S, Shimohama S, Kimura J, Masaki T. Purification of a novel endothelin-converting enzyme specific for big endothelin-3. FEBS Lett. 1998;428:304-308.
10. Yanagisawa H, Yanagisawa M, Kapur R, Richardson J, Williams S, Clouthier D, de Wit D, Emoto N, Hammer R. Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development. 1998;125:825-836.
11. Barnes K, Turner A. The endothelin system and endothelin-converting enzyme in the brain: molecular and cellular studies. Neurochem Res. 1997;22:1033-1040.
12. Schweizer A, Valdenaire O, Nelbock P, Deuschle U, Edwards JDM, Stumpf JG, Loffler B. Human endothelin converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochem J. 1997;328:871-877.
13. Valdenaire O, Lepailleur-Enouf D, Egidy G, Thouard A, Barret A, Vranckx R, Tougard C, Michel JB. A fourth isoform of endothelin converting enzyme (ECE-1) is generated from an additional promoter: molecular cloning and characterization. Eur J Biochem. 1999;264:341-349.
14. Valdenaire O, Barret A, Schweizer A, Rohrbacher E, Mongiat F, Pinet F, Corvol P, Tougard C. Two di-leucine-based motifs account for different subcellular localizations of the human endothelin-converting enzyme (ECE-1) isoforms. J Cell Science. 1999;112:3115-3125.
15. Nowak G, Pestic-Dragovich L, Hozak P, Philimonenko A, Simerly C, Schatten G, de Lanerolle P. Evidence for the presence of myosin I in the nucleus. J Biol Chem. 1997;272:17176-17181.
16. Brooks SC, Ergul A. Role of hydrophobic transmembrane domain in membrane anchoring of endothelin-converting enyzme-1a. J Cardiovasc Pharmacol. 2000;36(suppl 1):S30-S32.
17. Barnes K, Brown C, Tumer A. Endothelin-converting enzyme: ultrastructural localization and its recycling from the cell surface. Hypertension. 1998;31:3-9.
18. Zhou Y, Ching YP, Chun AC, Jin DY. Nuclear localization of the cell cycle regulator CDHI and its regulation by phosphorylation. J Biol Chem. 2003;278:12530-12536.
19. Brooks CS, Fernandez L, Ergul A. Secretion of endothelin converting enzyme-1 a: the hydrophobic signal anchor domain alone is not sufficient to promote membrane localization. Mol Cell Biochem. 2000;208:45-51.
20. Russell FD, Davenport AP. Secretory pathways in endothelin synthesis. Br J Pharmacol. 1999;126:391-398.
21. Fukui S, Otani N, Nawashiro H, Yano A, Nomura N, Miyazawa T, Ohnuki A, Tsuzuki N, Katoh H, Ishihara S, Shima K. Subcellular localization of basic fibroblast growth factor and fibroblast growth factor receptor 1 in pituitary adenomas. Brain Tumor Pathol. 2002;19:23-29.